Rostafuroxin
Chemical compound
From Wikipedia, the free encyclopedia
Rostafuroxin is a digitoxigenin analog that has been shown to lower blood pressure in an animal model of hypertension.[1] It modulates the effects of the enzyme Na+/K+-ATPase,[1] which maintains sodium and potassium ion gradients across plasma membranes. Rostafuroxin is being studied in clinical trials for the treatment of essential hypertension.[2][3]
| Names | |
|---|---|
| IUPAC name
21,23-Epoxy-24-nor-5β-chola-20,22-diene-3β,14β,17-triol | |
| Systematic IUPAC name
(1S,3aS,3bR,5aR,7S,9aS,9bS,11aS)-1-(Furan-3-yl)-9a,11a-dimethylhexadecahydro-3aH-cyclopenta[a]phenanthrene-1,3a,7-triol | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C23H34O4 | |
| Molar mass | 374.521 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
